Mananquil, Kim Judel .
HRN: 19-50-47 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/02/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/02/2022
11/09/2022
IV
1/4 Vial (250mg Ampicillin)
Q6
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes